compass_positive_tagline-01.png
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
08 juin 2021 07h00 HE | COMPASS Pathfinder Ltd.
LONDON, June 08, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
compass_positive_tagline-01.png
COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
03 juin 2021 09h27 HE | COMPASS Pathfinder Ltd.
LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
compass_positive_tagline-01.png
COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021
13 mai 2021 07h00 HE | COMPASS Pathfinder Ltd.
Highlights: New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder Two...
compass_positive_tagline-01.png
COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021
06 mai 2021 08h00 HE | COMPASS Pathfinder Ltd.
London, UK, May 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
compass_positive_tagline-01.png
COMPASS Pathways announces pricing of public offering
29 avr. 2021 20h45 HE | COMPASS Pathfinder Ltd.
      London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based...
compass_positive_tagline-01.png
COMPASS Pathways launches proposed public offering
27 avr. 2021 17h22 HE | COMPASS Pathfinder Ltd.
London, UK, April 27, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
compass_positive_tagline-01.png
New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
15 avr. 2021 03h00 HE | COMPASS Pathfinder Ltd.
London, UK, April 15, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
compass_positive_tagline-01.png
COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference
09 avr. 2021 07h00 HE | COMPASS Pathfinder Ltd.
London, UK, April 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
compass_positive_tagline-01.png
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors
01 avr. 2021 07h01 HE | COMPASS Pathfinder Ltd.
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors London, UK – 1 April 2021         COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated...
compass_positive_tagline-01.png
COMPASS Pathways granted two US patents
23 mars 2021 08h00 HE | COMPASS Pathfinder Ltd.
COMPASS Pathways granted two US patents London, UK – 23 March 2021     COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access...